About the journal
Immunology Letters is a journal published by Elsevier BV in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,120 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 0165-2478 · 1879-0542
- Country
- Netherlands
- Access
- Not open access / not declared
- Declared publication charge
- 3,120 USD
- Declared peer-review model
- peer_review
- Official website
- https://www.journals.elsevier.com/immunology-letters
Index listings
- MEDLINE · 1981-01-01
- PUBMED · 1986-10-15
- Indexing
- MEDLINE · PUBMED
- APC
- 3,120 USD
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
11508
Last recorded publication year
2026
h-index
136
i10-index
4096
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 91%
- ORCID iDs in current deposits
- 71%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Source type
- journal
- NLM unique ID (PubMed)
- 7910006
- Society affiliations
- European Federation of Immunological Societies
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
Show all subjects (50)
- Immune Response and Inflammation
- Immune Response and Inflammation
- Glycosylation and Glycoproteins Research
- Glycosylation and Glycoproteins Research
- Cell Adhesion Molecules Research
- Cell Adhesion Molecules Research
- HIV Research and Treatment
- HIV Research and Treatment
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- Cytokine Signaling Pathways and Interactions
- Cytokine Signaling Pathways and Interactions
- CAR-T cell therapy research
- CAR-T cell therapy research
- Diabetes and associated disorders
- Diabetes and associated disorders
- Immune cells in cancer
- Immune cells in cancer
- Asthma and respiratory diseases
- Asthma and respiratory diseases
- Systemic Lupus Erythematosus Research
- Systemic Lupus Erythematosus Research
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cytomegalovirus and herpesvirus research
- Cytomegalovirus and herpesvirus research
- Chemokine receptors and signaling
- Chemokine receptors and signaling
- Reproductive System and Pregnancy
- Reproductive System and Pregnancy
- Complement system in diseases
- Complement system in diseases
- Toxin Mechanisms and Immunotoxins
- Toxin Mechanisms and Immunotoxins
- vaccines and immunoinformatics approaches
- vaccines and immunoinformatics approaches
- Blood groups and transfusion
- Blood groups and transfusion
- NF-κB Signaling Pathways
- NF-κB Signaling Pathways
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ